AFT Pharmaceuticals (ASX:AFP) Net Change in Cash: A$0.5 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ASX:AFP AFT Pharmaceuticals Ltd ASX:AFP
76 GF Score
Price A$3.86
GF Value A$3.37
Valuation Modestly Overvalued
! 6 Warning Signs
View Full Analysis

What is AFT Pharmaceuticals Net Change in Cash?

AFT Pharmaceuticals ASX:AFP -0.26% 76 Net Change in Cash is A$0.5 Mil as of Mar. 2026. GuruFocus rates ASX:AFP with a GF Score™ of 76/100 and a GF Value™ of A$3.37 (Modestly Overvalued). The stock has 6 warning signs investors should review.

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

AFT Pharmaceuticals's Net Change in Cash for the six months ended in Mar. 2026 was A$0.4 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2026 was A$0.5 Mil.

AFT Pharmaceuticals Net Change in Cash Historical Data

* Premium members only.

The historical data trend for AFT Pharmaceuticals's Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AFT Pharmaceuticals Net Change in Cash Chart

AFT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.41 -4.32 8.12 -0.85 0.51

AFT Pharmaceuticals Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.77 -1.24 0.39 0.09 0.42
ASX:AFP
76GF Score
AFT Pharmaceuticals Ltd ASX:AFP
Net Change in Cash is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

AFT Pharmaceuticals Net Change in Cash Calculation

AFT Pharmaceuticals's Net Change in Cash for the fiscal year that ended in Mar. 2026 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-7.949+-8.131+7.328+9.258
=0.5

AFT Pharmaceuticals's Net Change in Cash for the quarter that ended in Mar. 2026

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-8.346+-5.218+4.784+9.202
=0.4

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2026 adds up the semi-annually data reported by the company within the most recent 12 months, which was A$0.5 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Net Change in Cash →
What does a Net Change in Cash of A$0.5 Mil mean?
AFT Pharmaceuticals (ASX:AFP) has a Net Change in Cash of A$0.5 Mil as of Mar. 2026. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for AFT Pharmaceuticals and its competitors.
Is AFT Pharmaceuticals' Net Change in Cash too high?
AFT Pharmaceuticals' current Net Change in Cash is A$0.5 Mil. Overall, AFT Pharmaceuticals has a GF Score™ of 76/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does AFT Pharmaceuticals' Net Change in Cash compare to ZTS and UTHR?
AFT Pharmaceuticals' Net Change in Cash of A$0.5 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Change in Cash for a Drug Manufacturers company?
A good Net Change in Cash depends on the Drug Manufacturers industry context. However, Net Change in Cash should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Change in Cash mean?
A high Net Change in Cash can signal that a stock is expensive relative to its fundamentals. The net change in cash is the total change in cash and equivalents between the current period and the past period. View historical data for AFT Pharmaceuticals and its competitors. AFT Pharmaceuticals's current Net Change in Cash is A$0.5 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AFT Pharmaceuticals stock overvalued right now?
Based on GuruFocus' analysis, AFT Pharmaceuticals (ASX:AFP) is currently considered Modestly Overvalued. The stock's GF Value™ is A$3.37, compared to a current price of A$3.86 — trading 14.5% above its estimated fair value. The current Net Change in Cash is A$0.5 Mil. AFT Pharmaceuticals' overall GF Score™ is 76/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Change in Cash calculated?
Net Change in Cash is calculated from a company's financial statements. For AFT Pharmaceuticals (ASX:AFP), the current Net Change in Cash is A$0.5 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is AFT Pharmaceuticals (ASX:AFP) Overvalued in 2026?

Based on GuruFocus' analysis, AFT Pharmaceuticals stock appears to be overvalued. The current stock price of A$3.86 is trading 14.5% above its estimated GF Value™ of A$3.37. GuruFocus considers AFT Pharmaceuticals to be Modestly Overvalued.

Key valuation signals for ASX:AFP:

  • Net Change in Cash: A$0.5 Mil
  • GF Value™: A$3.37 vs. price of A$3.86 (14.5% above fair value)
  • GF Score™: 76/100 with 6 warning signs

No single metric tells the full story. See the ASX:AFP stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

AFT Pharmaceuticals Business Description

Other Exchanges AFT:New Zealand
Address 129 Hurstmere Road, Level 1, Takapuna, Auckland, NTL, NZL, 0622
AFT Pharmaceuticals Ltd is a pharmaceutical distributor and developer of pharmaceutical intellectual property. Some of the products of the organization are Maxigesic dose forms, Capsaicin creams, Crystaderm, Kiwisoothe, Micolette, and others. The group has four operating segments based on geographical location being Australia, New Zealand, Asia, and the Rest of the world. It generates the majority of the revenue from Australia, which includes the sales and distribution activity relating to the Australian market.
76GF Score

Get the complete analysis for ASX:AFP

Net Change in Cash is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$3.86
Price
A$3.37
GF Value